Skip to main content

Part of the book series: Journal of Neural Transmission. Supplementa ((NEURAL SUPPL,volume 54))

Summary

After a brief discussion of the theory of disturbed neuronal calcium metabolism an overview is given on the results of clinical studies with nimodipine in the treatment of vascular and Alzheimer’s dementia.

Calcium seems to be the essential if not the only intracellular signal transmitter, on which all the signals transduced by the different transmitter systems converge, modulating the intracellular calcium concentration. Secondly disturbance to the intracellular calcium homeostasis is the common mechanism by which noxious interventions, like for instance hypoxia, deteriorate cell function, and finally even lead to cell death. There have been many experimental data showing that the ability of cells to sustaine calcium homeostasis might be impaired by the aging process itself. The hypothesis has been postulated, that this impairment might also be of central importance for brain aging, associated cognitive decline and development of dementia. In that sense the age dependent increasing incapacitation of the intraneuronal calcium regulating processes could be viewed as risk factors causing the increasing susceptibility of brain cells against any noxious agents including etiology of dementia in general and Alzheimer’s dementia in particular. Khachaturian (1989) has argued that a longlasting continuous and rather small impairment of calcium homeostasis may have the same effect as an acute and massive calcium overloading of neuronal cells as for example induced by acute ischemic states.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Etcheberrigaray R, Ito E, Oka K, et al (1994) Soluble β-amyloid induction of Alzheimer’s phenotype for human fibroblast K+ channels. Science 264: 276–279

    Article  PubMed  CAS  Google Scholar 

  • Fischhof P, Wagner G, Littschauer, et al (1989) Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York Tokyo, pp 350–359

    Chapter  Google Scholar 

  • Grobe-Einsler R (1993) Clinical aspects of nimodipine. Clin Neuropharmacol 16 [Suppl 1]: 39–45

    Article  Google Scholar 

  • Hartmann H, Eckert A, Velbinger K, et al (1996) Down-regulation of free intracellular calcium in dissociated brain cells of aged mice and rats. Life Sci 59: 435–449

    Article  PubMed  CAS  Google Scholar 

  • Kanowski S, Fischhof P, Hiersemenzel R, et al (1988) Wirksamkeitsnachweis von Nootropika am Beispiel von Nimodipin — ein Beitrag zur Entwicklung geeigneter klinischer Prüfmodelle. Z Gerontopsychol psychiatr 1: 35–44

    Google Scholar 

  • Kanowski S, Fischhof P, Hiersemenzel R, et al (1989) Therapeutic efficacy of nootropic drugs — A discussion of clinical phase III studies with nimodipine as a model. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York Tokyo, pp 339–349

    Chapter  Google Scholar 

  • Khachaturian ZS (1989) The role of calcium regulation in brain aging: reexamination of a hypothesis. Aging 1: 17–34

    PubMed  CAS  Google Scholar 

  • Morich FJ, Bieber F, Lewis JM, et al (1996) Nimodipine in the treatment of probable Alzheimer’s disease. Results of two multicenter trials. Clin Drug Invest 11: 185–195

    Article  CAS  Google Scholar 

  • Müller WE, Eckert A, Hartmann H, et al (1996) Zur Kalziumhypothese der Hirnalterung. Nervenarzt 67: 15–24

    PubMed  Google Scholar 

  • Schmage N, Dycka J (1991) Auswertung von verschiedenen psychometrischen Verfahren aus klinischen Studien mit Nimodipin. In: Möller H-J (Hrsg) Hirnleistungsstörungen im Alter. Springer, Berlin Heidelberg New York Tokyo, pp 97–104

    Chapter  Google Scholar 

  • Schmage N, Bergener M (1992) Global rating, symptoms, behaviour and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Int Psychogeratr 4: 89–99

    Google Scholar 

  • Zirm B, Steinwachs KC, Pracher G, et al (1994) Effects of nimodipine and piracetam on speed of information processing (ZVT: G) and clinical dementia symptoms — results of an unicenter randomized clinical trial. Z Gerontopsychol psychiatr 7: 157–168

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag/Wien

About this paper

Cite this paper

Kanowski, S. (1998). Aging, dementia and calcium metabolism. In: Gertz, HJ., Arendt, T. (eds) Alzheimer’s Disease — From Basic Research to Clinical Applications. Journal of Neural Transmission. Supplementa, vol 54. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7508-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-7508-8_19

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83112-0

  • Online ISBN: 978-3-7091-7508-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics